Bio Essence Corp
BIOE· OTC
Filed Nov 13, 2023 · 10-Q · 44 days after period end · 0001213900-23-085846
| Metric | Q3 2023 | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|---|
| Revenue | $155.70K | $192.05K | $226.99K | $228.33K |
| Net Income | -$314.84K | -$199.23K | -$183.04K | -$204.71K |
| EPS Diluted | -$0.01 | -$0.01 | -$0.01 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio Essence Corp · CIK 1723059 · Engraved from SEC EDGAR
ended Sep 30, 2023 · filed Nov 13, 2023 · 44 d after period end